@kidneycan.bsky.socialThe American Association for Cancer Research (AACR) Scholar-in-Training Awards will support early-career investigators focused on kidney cancer research.
IMPORTANT: You must apply for AACR Associate Membership by TODAY, October 9, to be eligible!
@kidneycan.bsky.socialClinical trials may be available at many different points in the #KidneyCancer treatment journey. Exploring what’s available can give you more information to discuss with your healthcare team.
@kidneycan.bsky.socialOnly about 7% of patients with cancer in the U.S. participate in cancer treatment clinical trials.
The Clinical Trial Navigator was created to help identify potential trial matches you can discuss with your healthcare team: https://kidneycan.org/clinical-trial-navigator/
@kidneycan.bsky.socialCould #KidneyCancer run in your family?
Join us October 28 for our FREE Town Hall, Genetics and Kidney Cancer: From Family Risk to the Future of Patient Care.
Register: https://kidneycan.org/genetics-kidney-cancer-family-risk
@kidneycan.bsky.socialThis is the 5th IKCC Global Patient Survey, marking 10 years of collecting data specific to the experiences of people living with #KidneyCancer. This milestone makes it possible to track trends and demonstrate changes over time.
@kidneycan.bsky.socialPowered by AI and built specifically for people with #KidneyCancer, the Clinical Trial Navigator helps make complex clinical trial information easier to search and understand.
@kidneycan.bsky.socialJoin the Judy Nicholson Foundation for Hope in Motion—a FREE day of kidney cancer education for patients & caregivers in Jacksonville, FL, on Oct. 9.
Bring your questions. Hear from experts. Connect with others.
@kidneycan.bsky.socialNeed some direction when it comes to clinical trials?
Meet the KidneyCAN Clinical Trial Navigator—a free, AI-powered tool designed specifically to help people with #KidneyCancer explore trials that may be relevant to them.
@kidneycan.bsky.socialWhy participate in the Global Patient Survey on #KidneyCancer? The information gathered helps create education, support and advocacy programs that respond to the needs of people affected by kidney cancer.
Take the survey: https://bit.ly/IKCC_Kidney_Cancer_Global_Survey
@kidneycan.bsky.socialChanges are coming to health coverage, and it's important to understand what they could mean for you. TOMORROW, October 1, Triage Cancer is hosting "Understanding Changes to Medicaid & the Marketplace: What Patients and Caregivers Need to Know."
@kidneycan.bsky.socialBoth clinical and translational research play an important role in advancing our understanding of #KidneyCancer. And the two often work hand in hand. What researchers learn in the lab can help shape clinical studies, while observations from patients can lead to new questions.
@kidneycan.bsky.socialAdvocate Andrew Allers is living with stage IV kidney cancer with brain metastases. His piece, Persistence, is a digital composite created from different slices of his own brain MRI. During our advocacy day, he left the piece in the office of his rep, Congressman Jim Himes.
@kidneycan.bsky.socialOn World Cancer Research Day, KidneyCAN & the International Kidney Cancer Coalition have launched the Global Patient Survey on Kidney Cancer! All #KidneyCancer patients, carers, & survivors are invited to share their experiences.
@kidneycan.bsky.socialHappy #WorldCancerResearchDay! In #KidneyCancer, research has transformed our understanding of the disease and continues to open new possibilities for diagnosis, treatment, and care. But there is still more to learn and more progress to make.
@kidneycan.bsky.socialWe’re excited to announce that the KCRS26 Abstract Supplement has been published in The Oncologist, featuring research presented as part of #KCRS!
Explore the full supplement: https://academic.oup.com/oncolo/issue/31/Supplement_3
@kidneycan.bsky.socialMark your calendar! The Triage Cancer Health Conference, happening online November 6–7, will cover topics that can make a real difference when navigating a serious or chronic medical condition.
Learn more: https://triagecancer.org/conferences/november-2026
@kidneycan.bsky.socialToday, on Rare Cancer Day, we recognize the people impacted by rare cancers.
Several kidney cancer subtypes are rare, including chromophobe and translocation RCC. Every patient deserves answers. And every person facing a rare cancer deserves a community.
@kidneycan.bsky.socialKidneyCAN Advocacy Days would not be possible without the generous support of our sponsors. Thank you to the organizations helping make it possible for #KidneyCancer advocates to bring the needs of the kidney cancer community directly to policymakers.
@kidneycan.bsky.socialThe progress we've made didn't happen by accident. It was made possible by researchers pursuing new discoveries, patients participating in research, and advocates making sure #KidneyCancer remains part of the conversation in Washington.
@kidneycan.bsky.socialOur Virtual Advocacy Day is underway!
Today, #KidneyCancer advocates are connecting with congressional offices virtually to share their stories and speak up for the needs of patients, caregivers, and families affected by kidney cancer.
